Leonhard Möckl

Leonhard Möckl is a Professor of Nano-optical Imaging at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and an Associated Group Leader at the Max Planck Institute for the Science of Light. He holds a PhD from LMU Munich (2015) and completed postdoctoral research at Stanford University (2016–2020), focusing on glycocalyx dynamics using super-resolution microscopy and deep learning. His research integrates biophysics, nanotechnology, and computational methods to study cell membrane organization and disease mechanisms.

Key research areas include glycocalyx architecture, single-molecule imaging, and nano-optical techniques for biomedical applications. He leads the Physical Glycosciences Research Group, developing tools like XLuminA for automated microscopy design and novel drug delivery systems. Notable contributions include studies on RNA-binding proteins in leukemia treatment and glycocalyx-based drug targeting.

Publications span high-impact journals like Nature Biotechnology, Cell, and Nature Communications, reflecting his expertise in imaging, glycobiology, and molecular pharmacology. His work bridges fundamental science and translational medicine, addressing challenges in cancer therapy, infectious diseases, and cell engineering.